C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease

Biochim Biophys Acta Mol Basis Dis. 2018 Dec;1864(12):3714-3725. doi: 10.1016/j.bbadis.2018.10.003. Epub 2018 Oct 2.

Abstract

Parkinson's disease (PD) is a common neurodegenerative disease which usually associates with neuroinflammation. The main pathological characteristics of PD are dopaminergic neurons death and the presence of Lewy bodies which are composed of aggregated α-synuclein (α-Syn). Truncated forms of α-Syn are found in the brain of PD patients, and account for 10-30% of total synuclein in Lewy bodies. Caspase-1, which plays an important role in neuroinflammation, cleaves full-length α-Syn (α-Syn FL) to generate a C-terminus 19-residues truncated α-Syn (α-Syn121). However, the role of truncated α-Syn in the onset and/or pathogenesis of PD is unclear. Here, we used α-Syn121 as a model to explore its aggregation, membrane disruption and cytotoxicity properties. Compared with α-Syn FL, α-Syn121 aggregated at an accelerated rate, and formed amorphous aggregates rich in random coil structures rather than β-sheet-rich linear fibrils formed by α-Syn FL. Importantly, higher cytotoxicity with lower membrane disruption capacity was found for α-Syn121 aggregates. Furthermore, α-Syn121 aggregates could activate the apoptosis signaling pathway and stimulate the caspase-1-mediated cleavage of α-Syn FL to generate α-Syn121, which as a result leading to increased levels of endogenous α-Syn121 and intracellular S129 phosphorylated α-Syn inclusions. Together, our data suggests a hidden vicious cycle in PD that α-Syn121 rapidly forms amorphous aggregates, which activate caspase-1 to cleave α-Syn FL and generate more α-Syn121, and this cycle may contribute to the onset and/or pathogenesis of PD.

Keywords: Alpha-synuclein; Caspase-1; Cytotoxicity; Parkinson's disease; Truncation; Vicious cycle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid / analysis
  • Amyloid / metabolism
  • Apoptosis
  • Caspase 1 / metabolism*
  • Cell Line
  • Humans
  • Parkinson Disease / metabolism*
  • Parkinson Disease / pathology
  • Protein Aggregates
  • Protein Aggregation, Pathological / metabolism*
  • Protein Aggregation, Pathological / pathology
  • Protein Structure, Secondary
  • Proteolysis
  • Reactive Oxygen Species / metabolism
  • alpha-Synuclein / analysis
  • alpha-Synuclein / metabolism*

Substances

  • Amyloid
  • Protein Aggregates
  • Reactive Oxygen Species
  • alpha-Synuclein
  • Caspase 1